van Schoor, N. & Lips, P. Global overview of vitamin D status. Endocrinology and Metabolism Clinical N.Am. 46(4), 845–870 (2017).
Carlberg, C., Raczyk, M., Zawrotna, N. Vitamin D: a prime example of nutritional genomics. Redox Biology 62102695 (2023).
Dhas, Y., Banerjee, J., Damle, G. & Mishra, N. Association between vitamin D deficiency and insulin resistance in middle-aged type 2 diabetic patients. Clinical Medicine Acta 49295–101 (2019).
Actor, S. etc Serum 25-hydroxyvitamin D3 and risk of type 2 diabetes in Japanese adults: Hitachi Health Study. Clinical Nutrition 39(4), 1218–1224 (2020).
Pittas, A.G. etc Vitamin D and type 2 diabetes risk in patients with prediabetes: A systematic review and meta-analysis of individual participant data from three randomized clinical trials. An Intern Med 176(3), 355–363 (2023).
Afzal, S., Bojesen, SE, Nordestgaard, B.G. Low 25-hydroxyvitamin D and risk of type 2 diabetes: a prospective cohort study and meta-analysis. Clinical Chemistry 59(2), 381-391 (2013).
Gagnon, C. etc Serum 25-hydroxyvitamin D, calcium intake, and risk of type 2 diabetes mellitus after 5 years: results from a nationwide, population-based, prospective study (the Australian Diabetes, Obesity and Lifestyle Study). Diabetes Care 34(5), 1133–1138 (2011).
Abbas, M. A. Physiological functions of vitamin D in adipose tissue. Journal of Steroid Biochemistry (JST) 165(Part B), 369–381 (2017).
Fan, Y. etc Vitamin D3/VDR resists diet-induced obesity by regulating UCP3 expression in muscle. Journal of Biomedical Sciences twenty three(1), 56 (2016).
Tao, LC, Xu, JN, Wang, TT, Hua, F. & Li, JJ Triglyceride-glucose index as a marker of cardiovascular disease: current status and limitations. Cardiovascular. Diabetes. twenty one(1), 68 (2022).
Do, T. etc Clinical utility of lipid ratios, visceral fat index, triglyceride and glucose index as risk markers for insulin resistance. Cardiovascular. Diabetes. 13146 (2014).
Huang, R. etc Utility of four surrogate indices of insulin resistance in a middle-aged population in Hefei, China. Anne Med 54(1), 622–632 (2022).
Zhang, M. etc Increased cumulative risk of developing type 2 diabetes mellitus with increasing triglyceride glycemic index in normal-weight individuals: a Chinese rural cohort study. Cardiovascular. Diabetes. 16(1), 30 (2017).
Xuan, X. etc U-shaped association between triglyceride-glucose index and risk of incident diabetes in normoglycemic individuals: a population-based longitudinal cohort study. Clinical Nutrition 40(4), 1555–1561 (2021).
Zou, S. etc Association between triglyceride-glucose index and incidence of diabetes in people with different obesity phenotypes: a retrospective study. Front. Endocrinology. (Lausanne) 12784616 (2021).
Pan, Y. etc Relationship between diabetic complications and triglyceride-glucose index in hospitalized patients with type 2 diabetes. Journal of Diabetes Research 20218757996 (2021).
Mustafa, A. & Shekhar, C. Association between serum 25-hydroxyvitamin D and triglyceride-glucose index in Indian adolescents. BMC Neutral 8(1), 69 (2022).
Jia, Y., Song, T., Li, Z., Zhou, L. & Chen, S. Relationship between triglyceride glycemic index and vitamin D in type 2 diabetes. Diabetes, metabolic syndrome, obesity 15511–525 (2022).
Sho, Q. etc Relationship between triglyceride-glucose index and vitamin D status in type 2 diabetes. Nutrients 15(3), 639 (2023).
Bouillon, R. etc Skeletal and extraskeletal actions of vitamin D: current evidence and unresolved questions. Endocrinology revised edition 40(4), 1109–1151 (2019).
Ning, Z. etc High prevalence of vitamin D deficiency among urban health screening subjects. Clinical Nutrition 35(4), 859–863 (2016).
Dominguez, LJ, Farruggia, M., Veronese, N. & Barbagallo, M. Vitamin D sources, metabolism and deficiency: available compounds and treatment guidelines. Metabolites 11(4), 255 (2021).
Lu, Hong Kong etc High prevalence of vitamin D deficiency in China: relationship with parathyroid hormone levels and bone metabolism markers. PLoS One 7(11), e47264 (2012).
Zhen, D., Liu, L., Guan, C., Zhao, N. & Tang, X. High prevalence of vitamin D deficiency among middle-aged and elderly people in northwestern China: relationship with osteoporosis and lifestyle factors. Bone 711–6 (2015).
Yu, S. etc High prevalence of vitamin D deficiency in China: a multicenter vitamin D status survey. Medicine (Baltimore) 94(8), e585 (2015).
Hossein-nezhad, A. & Holick, M. F. Vitamin D for health: a global perspective. Mayo Clinical Research 88(7), 720–755 (2013).
Chaktura, M. etc Vitamin D supplementation and fractures in adults: a systematic comprehensive review of meta-analyses of controlled trials. J. Clinical Endocrinology and Metabolism 107(3), 882–898 (2022).
Pittas, A.G., Jorde, R., Kawahara, T. & Dawson-Hughes, B. Vitamin D supplementation for the prevention of type 2 diabetes: to take D or not to take D? J. Clinical Endocrinology and Metabolism 105(12), 3721–3733 (2020).
Mitri, J., Dawson-Hughes, B., Hu, FB & Pittas, AG Effects of vitamin D and calcium supplementation on pancreatic beta cell function, insulin sensitivity, and blood glucose levels in adults at high risk of diabetes: a randomized controlled trial of calcium and vitamin D for diabetes (CaDDM). Am. J. Clin. Nutr. 94(2), 486-494 (2011).
Davidson, MB, Duran, P., Lee, ML & Friedman, TC High-dose vitamin D supplementation for patients with prediabetes and vitamin D deficiency. Diabetes Care 36(2), 260-266 (2013).
Gulseth, HL, Wium, C., Angel, K., Eriksen, EF & Birkeland, KI The effect of vitamin D supplementation on insulin sensitivity and insulin secretion in patients with type 2 diabetes and vitamin D deficiency: a randomized controlled trial. Diabetes Care 40(7), 872–878 (2017).
Cojic, M., Kocic, R., Klisic, A. & Kocic, G. Effects of vitamin D supplementation on metabolic and oxidative stress markers in patients with type 2 diabetes: a 6-month follow-up randomized controlled trial. Front. Endocrinology. (Lausanne) 12610893 (2021).
Kozik, M. etc Novel mechanisms of anti-inflammatory/antioxidant potential of vitamin D in type 2 diabetes patients receiving metformin therapy. Architecture, Medicine, Science 16(5), 1004–1012 (2020).
Pramono, A., Jocken, JWE & Blaak, EE Vitamin D deficiency in the pathogenesis of obesity-associated insulin resistance. Diabetes Metabolism Research Revised Edition 35(5), e3146 (2019).
Wanberg, L. etc Expression of vitamin D metabolic enzymes in human adipose tissue-effects of obesity and diet-induced weight loss. Int. J. Obes. (London) 37(5), 651-657 (2013).
Wortsman, J., Matsuoka, LY, Chen, TC, Lu, Z. & Holick, MF Reduced vitamin D bioavailability in obesity. Am. J. Clin. Nutr. 72(3), 690-693 (2000).
Di Nishio, A. etc Impaired release of vitamin D in dysfunctional adipose tissue: new clues for vitamin D supplementation in obesity. J. Clinical Endocrinology and Metabolism 102(7), 2564–2574 (2017).
Gastaldelli, A. Measuring and estimating insulin resistance in clinical and research settings. Obesity (Silver Spring) 30(8), 1549–1563 (2022).
Matthews, D.R. etc Evaluating homeostatic models: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in humans. Diabetology 28(7), 412-419 (1985).